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Abstract. 
 
CASK
 
, the rat homolog of a gene (
 
LIN-2
 
) re-
quired for vulval differentiation in 
 
Caenorhabditis ele-
gans
 
, is expressed in mammalian brain, but its function 
in neurons is unknown. CASK is distributed in a punc-
tate somatodendritic pattern in neurons. By immu-
nogold EM, CASK protein is concentrated in synapses, 
but is also present at nonsynaptic membranes and in in-
tracellular compartments. This immunolocalization is 
consistent with biochemical studies showing the pres-
ence of CASK in soluble and synaptosomal membrane 
fractions and its enrichment in postsynaptic density 
fractions of rat brain. By yeast two-hybrid screening, a 
specific interaction was identified between the PDZ do-
main of CASK and the COOH terminal tail of synde-
can-2, a cell surface heparan sulfate proteoglycan 
(HSPG). The interaction was confirmed by coimmuno-
precipitation from heterologous cells. In brain, synde-
can-2 localizes specifically at synaptic junctions where it 
shows overlapping distribution with CASK, consistent 
with an interaction between these proteins in synapses. 
Cell surface HSPGs can bind to extracellular matrix 
proteins, and are required for the action of various hep-
arin-binding polypeptide growth/differentiation factors. 
The synaptic localization of CASK and syndecan sug-
gests a potential role for these proteins in adhesion and 
signaling at neuronal synapses.
Key words: CASK • LIN-2 • syndecan • heparan sul-
fate proteoglycan • PDZ domain
 
T
 
he
 
 membrane-associated guanylate kinase ho-
mologs (MAGUKs)
 
1
 
 are a large family of proteins
typically localized at cell junctions. MAGUKs have
a distinctive domain structure characterized by one or
more NH
 
2
 
-terminally located PDZ domains, a COOH-ter-
minally located guanylate kinase–like (GK) domain, and
an intervening SH3 domain (reviewed in Anderson, 1996;
Kim, 1995; Sheng and Kim, 1996). All these domains ap-
pear to be important for mediating specific protein–pro-
tein interactions (Kim et al., 1997; Kornau et al., 1997;
Sheng, 1996).
A role in the localization and clustering of synaptic ion
channels and receptors has been proposed for the PSD-95
family of MAGUKs, which appear to be important for
molecular organization of the postsynaptic membrane in
neurons (reviewed in Kornau et al., 1997; Sheng, 1996).
The interactions between ion channels and PSD-95 are
mediated by the PDZ domains of the MAGUK protein
binding directly to the cytoplasmic COOH-terminal tails
of the channel proteins. In addition to membrane ion
channels and receptors, PSD-95 family proteins also interact
with intracellular proteins involved in signaling or associ-
ated with the cytoskeleton, such as APC (Matsumine et
al., 1996), GKAP (Kim et al., 1997; Naisbitt et al., 1997; Sa-
toh et al., 1997; Takeuchi et al., 1997), protein 4.1 (Lue et
al., 1996; Marfatia et al., 1996), and neuronal nitric oxide
synthase (Brenman et al., 1996). Furthermore, members of
the PSD-95 family of MAGUKs can form homo- or hetero-
multimers with themselves, resulting in aggregation of
their binding partners (Hsueh et al., 1997; Kim et al., 1996;
Kim et al., 1997; Kim et al., 1995). A general picture now
emerging is that MAGUKs function as multidomain scaf-
fold proteins that organize specific signaling complexes at
defined membrane locations.
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1. 
 
Abbreviations used in this paper
 
: aa, amino acid; ECM, extracellular
matrix; EGFR, EGF receptor; HCASK, rabbit anti-human CASK; HSPG,
heparan sulfate proteoglycan; Kv1.4-EFYA, Kv1.4-syndecan-2 chimeric
protein; MAGUK, membrane associated guanylate kinase; MB, maleate
buffer; PB, phosphate buffer; PSD, postsynaptic density; SYN-2C, synde-
can-2 antibody.
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LIN-2 is a member of the MAGUK superfamily that
contains an NH
 
2
 
-terminal calmodulin-dependent kinase
(CaMK)-like domain preceding its single PDZ domain,
SH3 domain, and GK domain (Hoskins et al., 1996). In 
 
C.
elegans
 
, LIN-2 is required for vulval differentiation, and
may be involved in the proper localization of LET-23, an
EGF receptor (EGFR) homolog important in the vulval
differentiation pathway (Hoskins et al., 1996; Simske et al.,
1996). LIN-2 is thus genetically implicated in receptor ty-
rosine kinase signaling. However, it is not LIN-2 itself, but
another PDZ-containing protein, LIN-7, that binds di-
rectly to the intracellular COOH terminus of LET23/
EGFR (Simske et al., 1996). Hence, the biochemical and
cell biological functions of LIN-2 remain unclear. In par-
ticular, the physiological binding partner(s) for the PDZ
domain of LIN-2 are unknown.
LIN-2 homologs have been identified in 
 
Drosphila
 
 and
in mammals (Dimitratos et al., 1997; Hata et al., 1996). CASK,
a rat homolog of LIN-2, was isolated via its ability to bind
in the yeast two-hybrid system to the neurexins, a family of
neuronal cell surface proteins (Hata et al., 1996). Here we
show that via its PDZ domain, CASK/LIN-2 can bind di-
rectly to the COOH-terminal tail of the syndecans, a family
of transmembrane heparan sulfate proteoglycans (HSPGs).
We also report the subcellular distribution of CASK and syn-
decan-2 in neurons of rat brain at both light microscopy (LM)
and EM levels, and present evidence for an in vivo interac-
tion between CASK and syndecan in neuronal synapses.
 
Materials and Methods
 
Antibodies
 
CASK (CASK-FYG) antibodies and syndecan-2 (Syn-2C) antibodies
were raised in rabbits against the synthetic peptide CFYGDPPEELPDF-
SED, corresponding to amino acids 320–334 of CASK, and the synthetic
peptide RKKDEGSYDLGERKPSC, corresponding to amino acids 182–
197 of rat syndecan-2, respectively. The terminal cysteine residues were
added for coupling purposes. Both antibodies were affinity-purified using
their respective immunogen peptide coupled to a Sulfolink column (Pierce
Chemical Co., Rockford, IL). Rabbit anti-human CASK (hCASK) antise-
rum is described in Cohen et al. (cosubmitted manuscript). Anti-SAP97
and anti-PSD95 CSK antibodies were described in Kim et al. (1996). Anti-
Myc mouse monoclonal antibody (9E10) was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). MSE-2 antiserum, a gift from Dr. Mer-
ton Bernfield, was raised against the nonconserved extracellular region of
syndecan-2, and has been described (Kim et al., 1994).
 
Plasmid Constructs
 
Rat syndecan-2 cDNA was generously provided by Dr. Graham Cowling
(Manchester University, United Kingdom). The coding region of rat syn-
decan-2 was PCR-amplified and subcloned into the KpnI and EcoRI site
of mammalian expression vector GW1-CMV. Two oligonucleotides, one
containing an XbaI site, the myc epitope (EQKLISEEDL), and the se-
quence GACCTTGGAGAACGCAAACCG (corresponding to aa 190–
196 of syndecan-2), and the other containing an XbaI site and the se-
quence GTAGCTTTCTTCGTCTTTC TT (corresponding to aa 183–189
of rat syndecan-2), were applied in reverse PCR for construction of myc-
tagged syndecan-2. The amplified product was digested with XbaI and
then religated. The Kv1.4-syndecan-2 chimeric protein (Kv1.4-EFYA)
was constructed by PCR using Kv1.4 cDNA as template and a 3
 
9
 
 end
primer encoding the last four amino acids (aa) of syndecan-2 and aa 648–
651 of Kv1.4.
CASK cDNA was amplified by reverse transcription PCR from rat
brain first-strand cDNA library, and was subcloned into pGW1-CMV. In
addition, we obtained CASK cDNA as a gift from Dr. Thomas C. Südhof.
For myc-tagged CASK construction, an AscI site was created between aa
599 and 560 of CASK by inverse PCR. A double-stranded oligonucleotide
encoding the myc epitope was inserted into the AscI site.
 
Transfection, Immunoprecipitation, Biochemical 
Fractionation, and Immunoblotting
 
COS-7 cells in 35-mm plates at 50–70% confluency were incubated with a
1-ml OPTI-MEM (GIBCO BRL, Gaithersburg, MD) mixture containing
1.6 
 
m
 
g DNA and 6 
 
m
 
l Lipofectamine (GIBCO-BRL) for 5 h followed by
incubation in DMEM medium. 48 h later, cells were harvested and lysed
in RIPA buffer. Immunoprecipitation from RIPA cell lysates has been de-
scribed (Hsueh et al., 1997), except that Myc antibody 9E10-conjugated
agarose (Santa Cruz Biotechnology) was used to precipitate myc-tagged
proteins directly. Fractionation of brain membranes and PSDs was per-
formed as described by Cho et al. (1992). Immunoblotting with enhanced
chemiluminescence reagents was performed as described (Sheng et al.,
1993). hCASK antiserum was used at a 1:2,000 dilution; affinity-purified
primary antibodies were used at 2 
 
m
 
g/ml (Syn-2C antibody), 0.5 
 
m
 
g/ml
(CASK-FYG antibody), 0.2 
 
m
 
g/ml (PSD-95 CSK antibody), 1 
 
m
 
g/ml
(SAP97 antibody), or 0.2 
 
m
 
g/ml (anti-Myc antibody 9E10).
 
Immunohistochemistry
 
Immunohistochemistry was performed on Vibratome-cut (Ted Pella, Inc.,
Redding, CA) 50-
 
m
 
m floating brain sections from rats (
 
z
 
6 wk old; Harlan
Sprague Dawley Inc., Indianapolis, IN) perfused transcardiacally with 4%
paraformaldehyde and permeabilized with either 0.1% Triton X-100 or
50% ethanol. Rat brain sections were incubated with affinity-purified primary
antibodies at 2 
 
m
 
g/ml at room temperature overnight. For DAB staining,
Vectastain Elite ABC kit (Vector Labs, Inc., Burlingame, CA) was used as
described (Sheng et al., 1994). For immunofluorescent staining, Cy3- or
FITC-conjugated secondary antibodies (Jackson ImmunoResearch Labo-
ratories, Inc., West Grove, PA) were used at the dilution of 1:1,000 and
1:200, respectively.
Double-label immunofluorescence with two antibodies raised from the
same species (rabbit) was performed as described in Shindler and Roth
(1996) with some modifications. The brain sections were incubated with a
very low concentration (0.05 
 
m
 
g/ml) of Syn-2C antibodies in PBS with
0.5% blocking reagent (TSA direct kit; Dupont-NEN, Boston, MA) at
room temperature overnight. After washing three times with PBST (1
 
3
 
PBS with 0.05% Tween-20), the sections were incubated with biotinylated
anti-rabbit antibody (Jackson ImmunoResearch Laboratories, Inc.) at
1:1,000 at room temperature for 2 h, and were incubated with streptavi-
din-conjugated horseradish peroxidase (TSA direct kit; Dupont-NEN ) at
1:100 for a further 30–60 min. Finally, FITC-conjugated tyramide (TSA di-
rect kit; Dupont-NEN) was applied at 1:50 in amplification diluent (TSA
direct kit; Dupont-NEN) for 5–10 min. After washing three times with
PBST, these rat brain sections were then processed for conventional im-
munofluorescent CASK staining using Cy-3–conjugated secondary anti-
bodies as described above. At the low concentrations of Syn-2C antibodies
used, no Syn-2C signal could be detected with Cy3-conjugated anti-rabbit
secondary antibodies. Results were viewed with an Axioskop microscope
(Carl Zeiss Inc., Thornwood, NY) or a confocal microscope (MRC-1000;
Bio-Rad Laboratories, Hercules, CA), and digitized images were pro-
cessed for publication using Adobe Photoshop.
 
Electron Microscopy
 
For electron microscopy, pentobarbital-anesthetized (60 mg/kg) male
Sprague-Dawley rats (250–350 g) were perfused intraaortically with mixed
aldehyde fixatives (0.2% glutaraldehyde and 4% depolymerized para-
formaldehyde for immunoperoxidase staining; 2% glutaraldehyde and 2%
paraformaldehyde for immunogold) in phosphate buffer (PB), pH 7.4, af-
ter a brief flush with heparinized saline. The brain was removed and
immersed in the same fixative for 2 h; 40-
 
m
 
m sections were cut on a Vi-
bratome and collected in PB. For immunogold, sections were embedded
directly into resin (see below). For preembedding immunoperoxidase
staining, floating sections in glass vials were treated for 30 min in 1% so-
dium borohydride in PB, permeabilized for 30 min with 50% EtOH, and
then incubated for 10 min in 3% hydrogen peroxide, blocked in 10% don-
key serum, and incubated in primary antibody (diluted 1:100–1:1,l000) on
a shaker overnight. Sections were then rinsed, incubated in secondary an-
tibody (biotinylated, donkey anti–rabbit; Jackson ImmunoResearch Lab-
oratories, Inc., 1:200) for 2 h, rinsed, incubated in ExtrAvidin (1:5,000; 
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Sigma Chemical Co., St. Louis, MO) for 2 h, rinsed, and reacted with di-
aminobenzidine to visualize antibody-binding sites. Sections were then
poststained 1 h in 1% platinum chloride in maleate buffer (MB) and infil-
trated with resin.
Embedding was performed according to modifications of an osmium-
free protocol (Phend et al., 1995). In brief, sections were incubated over
ice in 0.1% filipin/0.1% digitonin (Sigma Chemical Co.) in MB for 20 min,
for 40 min with 1% tannic acid in MB, for 20 min in 0.1% CaCl
 
2
 
, for 40 min
in 1% uranyl acetate, and then for 20 min in 0.5% IrBr
 
4
 
 (Pfaltz and Bauer,
Inc., Waterbury, CT). Sections were dehydrated through graded alcohols
and propylene oxide, and then infiltrated with Epon-Spurr resin (Electron
Microscopy Sciences, Fort Washington, PA). Wafers prepared with
ACLAR plastic (Pelco; Ted Pella, Inc.) were polymerized at 60
 
8
 
C for 24–
36 h. Small chips of the polymerized wafers were glued to plastic blocks;
and thin sections cut with a diamond knife were collected on copper mesh
grids, poststained with uranyl acetate and lead citrate, and examined with
a CX200 microscope (JEOL USA, Inc., Peabody, MA). For immunogold
staining, sections were collected on nickel mesh grids and processed ac-
cording to methods described in Phend et al. (1992). Primary antibody
concentrations were 1:100–1:400; the secondary was donkey anti-rabbit se-
rum, conjugated to 18-nm gold particles (Jackson ImmunoResearch Labo-
ratories, Inc.). After immunoprocessing, grids were briefly immersed in
1% glutaraldehyde, rinsed, and poststained as described above.
 
Yeast Two-hybrid Screen and Analysis of
CASK-Syndecan-2 Interaction
 
Two-hybrid screening was done using the L40 yeast strain harboring re-
porter genes HIS3 and LacZ under the control of upstream LexA-binding
sites, as described previously (Kim et al., 1995). The PDZ domain of
hCASK (which is identical at the aa level with rat CASK) was subcloned
into pBHA (LexA fusion vector), and was used to screen rat and human
brain cDNA libraries constructed in pGAD10 (GAL4 activation domain
vector; CLONTECH Laboratories, Inc., Palo Alto, CA). COOH-terminal
deletion mutants of syndecan-2 were created by PCR and subcloned into
pGAD10 to generate GAL-4 activation domain fusions. The interactions
of CASK and syndecan were tested in yeast two-hybrid assays by using
HIS3 and LacZ as reporter genes (Kim et al., 1995).
 
Results
 
Subcellular Fractionation of CASK in Rat Brain
 
To study CASK expression in rat brain at the protein
level, we raised antibodies (termed CASK-FYG) against a
peptide sequence located between the CaMK and PDZ
domains of CASK. The specificity of these anti-CASK an-
tibodies was examined by Western blotting of transfected
heterologous cells and brain. CASK-FYG antibodies rec-
ognized a dominant band of 
 
z
 
110 kD in extracts of COS-7
cells transfected with CASK cDNA, but not with vector
alone (Fig. 1 
 
A
 
). In rat brain, CASK was detected as an
 
z
 
110-kD protein that is mainly associated with mem-
branes, though a significant fraction was also present in
soluble fractions (Fig. 1 
 
B
 
). By immunoblotting, CASK is
broadly expressed in several brain regions, including neo-
cortex, cerebellum, hippocampus, and brain stem. The
same 
 
z
 
110-kD band in brain and in CASK-transfected
COS cells was recognized by an independent antiserum
raised against an hCASK fusion protein (Fig. 1 
 
B
 
 and data
not shown).
The membrane-associated CASK further purified into
the postsynaptic density (PSD) fraction, in which it was re-
sistant to extraction by Triton X-100 (PSD I and PSD II)
and by Triton X-100 and sarkosyl (PSD III; Fig. 1 
 
C
 
). The
degree of CASK enrichment in the PSD fractions, how-
ever, was weaker than that seen with PSD-95, a standard
marker for PSDs (Fig. 1 
 
C
 
). Nevertheless, enrichment of
CASK in purified PSDs showed specificity, since SAP97,
Figure 1. Regional distribution and subcellular fractionation of
CASK in adult rat brain. (A) Specificity of CASK-FYG peptide
antibody. Lysates of COS-7 cells transfected with CASK cDNA
or vector alone were immunoblotted with affinity-purified
CASK-FYG antibodies. Arrowhead points to specific CASK
band of z110 kD. (B) Membrane association and regional ex-
pression of CASK. Whole-brain synaptosomal membrane and
soluble fractions, and synaptosomal membranes from different
regions of adult rat brain, were immunoblotted for CASK using
anti-hCASK antiserum. Lanes were loaded as follows (10 mg pro-
tein per lane): total memb, lysed crude synaptosomal membrane
fraction of whole brain; total soluble, S100 supernatant fraction
of whole brain; and lysed synaptosomal membranes from neocor-
tex (ctx), cerebellum (cb), hippocampus (hp), and brain stem
(bs). Identical results were obtained with CASK-FYG antibodies
(not shown). (C) Enrichment and detergent extractability of
CASK in PSD fractions, compared with PSD-95 and SAP97.
Lanes were loaded as follows: memb, lysed crude synaptosomal
membrane fraction from whole brain; purified PSD fractions ex-
tracted with Triton X-100 once (PSD I), twice (PSD II), or with
Triton X-100 followed by sarkosyl (PSD III). Amounts of protein
loaded in each lane are indicated. Detergent supernatants of each
PSD fraction (2 mg protein) were also immunoblotted. Positions
of molecular size standards are shown in kD. 
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an axonal and presynaptic protein (Müller et al., 1995),
was depleted in PSDs. These biochemical fractionation
studies suggest that CASK is present in the PSD, but that
it is not as selectively concentrated in synapses as is PSD-95.
This interpretation is supported by immunocytochemical
studies (see below).
 
Immunohistochemical Distribution of CASK in
Rat Brain
 
Affinity-purified CASK-FYG antibodies and anti-hCASK
antibodies were used to localize CASK in sections from
rat brain. As with Western blotting, these two indepen-
dent antibodies gave specific staining patterns that were
strikingly similar to each other (data not shown), provid-
ing strong support that they reveal the true distribution of
CASK protein. CASK protein is expressed widely in the
brain, and is distributed in a somatodendritic pattern, pre-
dominantly in neurons (Fig. 2). In cerebral cortex, pyrami-
dal cells showed strong immunoreactivity in cell bodies
and in apical dendrites; nuclei appeared unstained. The
apical dendritic staining extended from the proximal trunk
Figure 2. DAB immunohistochemistry of CASK
in adult rat brain. (A) Layer-specific staining in
neocortex; (B) heavily stained cortical layer 5 py-
ramidal neurons and their apical dendrites; (C)
hippocampal formation showing staining of den-
dritic fields in all regions and of mossy fiber tract.
Neurons show CASK immunoreactivity in a so-
matodendritic pattern; examples shown here are:
(D) granule cells of dentate gyrus; (E) pyramidal
neurons of CA3; (F) pyramidal neurons of CA1;
(G) neurons in the thalamus; and (H) Purkinje
cells of cerebellum. Staining was abolished by
preincubating CASK-FYG antibodies with ex-
cess immunogen peptide (not shown). DG, den-
tate gyrus; mf, mossy fiber tract; M, molecular
layer; P, Purkinje cell layer; G, granule cell layer;
W, white matter. Bars: (A) 100 mm; (B) 20 mm;
(C) 650 mm; (D–F) 30 mm; (G), 60 mm; and (H)
200 mm. 
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to the terminal branches, and was most prominent for
layer 5 pyramidal neurons (Fig. 2, 
 
A
 
 and 
 
B
 
). Layer 2/3 py-
ramidal neurons were also stained, though at lower inten-
sity, and layer 4 cells were relatively spared of labeling.
The punctate nature of CASK staining seen on pyramidal
cell dendrites is consistent with a synaptic localization
(Fig. 2 
 
B
 
), though there was also substantial intracellular
immunoreactivity in somata and proximal dendrites.
In the hippocampal formation, CASK protein was
present in dentate granule cells and in CA1 and CA3 pyra-
midal cells in a somatodendritic distribution (Fig. 2, 
 
C
 
–
 
F
 
).
In addition, however, staining was noted in the mossy fiber
tract (Fig. 2 
 
C
 
) where axons from the dentate gyrus gran-
ule cells run adjacent to the cell bodies of CA3 pyramidal
neurons. CASK immunoreactivity was also prominent in
neurons of the thalamus, especially in somata and proxi-
mal dendrites (Fig. 2 
 
G
 
). In the cerebellum, the cell bodies
and dendrites of Purkinje cells were intensely labeled, and
the granule cell layer showed moderate staining (Fig. 2 
 
H
 
).
In both forebrain and hindbrain, the neuropil showed sign-
ficant CASK staining, whereas white matter tracts were
relatively spared.
Higher resolution immunofluorescence confocal micros-
copy with CASK-FYG antibodies revealed punctate stain-
ing on top of a relatively diffuse staining in intracellular
compartments and in major dendrites (Fig. 3). Punctate la-
beling was most prominent along dendritic processes, sug-
gesting a possible synaptic localization of CASK. This sub-
cellular distribution pattern is exemplified in pyramidal
neurons of cortex and hippocampus (Fig. 3, 
 
A
 
–
 
D
 
). In cere-
bellum, CASK antibodies also revealed punctate staining
in somata and along major dendrites of Purkinje cells (Fig.
3, 
 
E
 
 and 
 
F
 
).
Ultrastructural localization of CASK was obtained by
postembedding immunogold EM. The highest density of
CASK labeling was found at asymmetric (presumed exci-
tatory) synapses (Fig. 4, 
 
A
 
, 
 
B
 
, 
 
E
 
, and 
 
F
 
), but was also seen
at symmetric (presumed inhibitory) synapses (Fig. 4, 
 
B
 
, 
 
C
 
,
and 
 
D
 
). Quantitative analysis of immunogold distribution
showed that the peak of CASK labeling was closely associ-
ated with the synaptic membranes, and was roughly sym-
metrically disposed across the synaptic cleft (see Fig. 8,
 
left
 
), implying the presence of CASK in both presynaptic
and postsynaptic compartments close to the membrane. In
addition to its association with synaptic membranes and
adjacent cytoplasm, CASK was also present at a lower
density at nonsynaptic membranes (Fig. 4, 
 
B
 
, 
 
C
 
, and 
 
F
 
; see
Fig. 8, 
 
right
 
). Cytoplasmic CASK labeling was observed in
somata and in dendritic shafts, where it appeared to be of-
ten associated with polyribosomes (Fig. 4 
 
B
 
). The pres-
ence of CASK in intracellular compartments is also re-
flected in the particle density plot (Fig. 8, 
 
left
 
), which
shows a broad major peak with smaller peaks of immu-
nogold density some distance (
 
z
 
100 nm) from the synap-
tic membranes. These ultrastructural findings correlate
well with the localization of CASK at the LM level.
In summary, CASK is distributed in a somatodendritic
pattern in neurons, and is enriched but not exclusively lo-
calized in synapses. CASK is also present at nonsynaptic
plasma membranes and in intracellular compartments.
These immunocytochemical findings are consistent with
the biochemical fractionation profile of CASK, which
shows incomplete membrane association (Fig. 1 
 
B
 
) and
only a moderate enrichment in PSD fractions (Fig. 1
 
 C
 
).
 
The CASK PDZ Domain Binds to the COOH Terminus 
of Syndecan
 
The COOH terminal tail of neurexin has been shown to
interact with CASK (Hata et al., 1996), possibly via
CASK’s PDZ domain. Since PDZ domains in general can
bind to multiple partners with compatible COOH-termi-
nal sequences (Kornau et al., 1997; Sheng, 1996; Sheng and
Kim, 1996; Songyang et al., 1997) as well as to heterolo-
gous PDZ domains (Brenman et al., 1996), we sought to
identify other potential ligands for CASK. Using the single
PDZ domain of CASK as bait in a yeast two-hybrid
screen, three interacting cDNA clones were isolated from
brain cDNA libraries (Table I). The most strongly inter-
acting cDNA encoded the COOH-terminal region of a
known protein, the transmembrane HSPG syndecan-2
(which terminates in the sequence -EFYA). The remain-
Figure 3. Localization of
CASK in rat brain neurons
by immunofluorescence con-
focal microscopy. Punctate
CASK immunoreactivity is
seen on top of diffuse intra-
cellular staining in neuronal
somata and dendrites. (A)
Layer 5 pyramidal cells of ce-
rebral cortex; (B) apical den-
drites of layer 5 pyramidal
cells; (C and D) CA1 pyrami-
dal neurons; (E and F) cell
body and dendrites of
Purkinje cells in the cerebel-
lum. A similar staining pat-
tern was seen with anti-
hCASK antiserum (not
shown). Bars: (A and B) 50
mm; (C and D), 10 mm; (E
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ing two cDNAs encoded the COOH-terminal regions of
two proteins of unknown function and with no homology
to other sequences in the database, one terminating in
-EFQV, and the other ending in -YFDV. Conservation of
the COOH-terminal sequence of the interacting clones
suggests that this region is involved in binding to the PDZ
domain of CASK. This result was confirmed by deletion of
the last three residues of syndecan-2, which abolished its
interaction with CASK’s PDZ in the two-hybrid system
(Table I). In the course of this analysis, we also confirmed
that the COOH terminus of neurexin can bind to the
CASK PDZ domain.
To confirm that full-length CASK and syndecan-2 pro-
teins can associate with each other, we performed coim-
munoprecipitation assays in heterologous cells. From COS
cells cotransfected with CASK and myc-tagged synde-
can-2, myc antibodies were able to precipitate CASK in
addition to myc-tagged syndecan-2 (Fig. 5 A). CASK ex-
pressed by itself, however, was not immunoprecipitated by
myc antibodies. These data indicate that full-length synde-
can-2 and full-length CASK can form a complex in a mam-
malian cell environment.
The results of yeast two-hybrid assays (Table I) indi-
cated that the COOH terminus of syndecan-2 is necessary
Figure 4. Subcellular localization of
CASK by immunogold EM. (A) Electron
micrograph of an asymmetric axospinous
synapse shows CASK labeling over synap-
tic membrane and postsynaptic density
(silver-intensified 1-nm gold particles used
to optimize accuracy of localization). (B)
Dendritic shaft immunopositive for
CASK. Labeling (18-nm gold particles)
is present over polyribosomes (arrow-
heads). Two synapses on this dendrite, one
of asymmetric type (asterisk, left), and an-
other of symmetric type (star, right) are
also labeled (arrows). CASK is also seen
at nonsynaptic plasma membranes. (C)
CASK-positive neuronal perikaryon (P)
contacted by two axon terminal–making
symmetric synapses (likely to use GABA
as transmitter); both synapses are immu-
nopositive for CASK (arrows). (D) Label-
ing associated with synaptic membranes
adjacent to the active zone of the axo-
spinous synapse. (E) Labeling over PSD
of asymmetric axospinous synapse. (F)
CASK labeling concentrated over two ob-
liquely sectioned axospinous synapses. An
additional gold particle is visible in the
spine cytoplasm; another nearby particle
is associated with the nonsynaptic plasma
membrane. (G) Presynaptic labeling at axo-
spinous synapse. Asterisks mark axon ter-
minals making asymmetric synaptic contacts;
stars mark terminals making symmetric
contacts. D, dendrite; m, mitochondrion; P,
perikaryon; Sp, spine. Bars, 200 nm.
for binding to the CASK PDZ domain. To test whether
the COOH-terminal residues are sufficient for this inter-
action, we constructed a Kv1.4-EFYA in which the last
four amino acids of the K1 channel Kv1.4 (-ETDV) are re-
placed by the corresponding syndecan-2 COOH terminus
(-EFYA). In heterologous cells, this Kv1.4-EFYA chi-
meric protein could be coprecipitated with myc-tagged
CASK by CASK-FYG antibodies (Fig. 5 B). In contrast,
wild-type Kv1.4 was not coprecipitated with CASK (Fig. 5
B), although it could be efficiently coimmunoprecipitated
with PSD-95 (Kim et al., 1996). These results indicate that
the COOH-terminal four amino acids of syndecan-2
(EFYA) are sufficient to confer CASK PDZ-binding on a
heterologous membrane protein. Since all four known
members of the syndecan family terminate with the identi-
cal sequence EFYA (Bernfield et al., 1992; Carey, 1997),
this finding implies that all four syndecans can bind to the
PDZ domain of CASK.
Synaptic Localization of Syndecan-2
To investigate the putative interaction of syndecan HSPGs
and CASK in vivo, we used Syn-2C to localize syndecan-2
in rat brain. At high resolution, the Syn-2C immunostain-Hsueh et al. CASK-Syndecan Interaction in Synapses 145
ing pattern in all regions of the brain was notably punctate
and suggestive of synaptic labeling (Fig. 6). The specific
concentration of Syn-2C immunoreactivity in synapses
was revealed by its colocalization with the synaptic vesicle
marker synaptophysin in double-labeling studies (Fig. 6).
Examples of punctate colocalization of Syn-2C and synap-
tophysin staining are shown from the stratum lucidum of the
hippocampus (Fig. 6 A), the neuropil of the cerebral cortex
(Fig. 6 B), the glomeruli of the granule cell layer of the cer-
ebellum (Fig. 6 C), and the glomeruli of the olfactory bulb
(Fig. 6 D). In all areas of the brain, cell bodies and major
dendrites were relatively spared of Syn-2C labeling (Fig. 6).
To confirm the specificity of Syn-2C staining, we per-
formed immunocytochemistry with a second independent
antiserum raised against the extracellular region of synde-
can-2. This antibody (MSE-2; Kim et al., 1994) gave a syn-
aptic pattern of staining similar to that of Syn-2C, includ-
ing the glomeruli of the cerebellar granular layer (Fig. 6
E). The similar staining pattern with two independent an-
tibodies to syndecan-2 provides strong evidence that syn-
decan-2 is specifically localized in neuronal synapses.
Localization of Syndecan in Synapses by
Immunogold EM
To verify the synaptic localization of syndecan-2 at ultra-
structural resolution, we performed EM immunocy-
tochemistry. Type 1 (asymmetric) synapses were specifi-
cally labeled by Syn-2C antibodies as revealed by
preembedding immunoperoxidase staining (Fig. 7 A).
Electron-dense reaction product was prominent at the
PSD as well as in the presynaptic axon terminal. Labeling
was observed close to the synaptic membrane, and in
many cases could also be seen some distance from the syn-
apse, particularly on the presynaptic side. Postembedding
immunogold staining confirmed a heavy concentration of
Syn-2C immunoreactivity, specifically at asymmetric syn-
apses. By far the highest density labeling was closely asso-
ciated with the synaptic membranes, but in addition a
lower density of particles was detected over the presynap-
tic axon terminal some distance from the synapse (Fig. 7,
B–D, F, and G; see quantitation in Fig. 8). Outside of
asymmetric synapses, Syn-2C labeling was present sparsely
at nonsynaptic sites of membrane–membrane apposition,
Figure 5. COOH-terminal
-EFYA motif of syndecan-2
is sufficient to mediate asso-
ciation with CASK. (A) Coim-
munoprecipitation of CASK
and syndecan-2. COS-7 cells
were transfected with CASK
and/or myc-tagged syndecan-2
as indicated, and were then
lysed and immunoprecipitated
with anti-myc antibodies. Im-
munoprecipitates were West-
ern-blotted for CASK and
myc-syndecan-2. CASK was
precipitated by anti-myc an-
tibody only when CASK was
coexpressed with myc-synde-
can-2. (B) The COOH-termi-
nal four aas of syndecan-2
are sufficient for association
with CASK. The COOH-ter-
minal sequences of Shaker
channel subunit Kv1.4 and
syndecan-2 are aligned at the
top. Kv1.4-EFYA chimeric construct contains full-length Kv1.4 except that the last four aas were substituted with the corresponding
syndecan-2 COOH terminus. COS-7 cells were transfected with various combinations of myc-tagged CASK, Kv1.4-EFYA, and wild-
type Kv1.4, as indicated. Immunoprecipitations were performed with CASK-FYG antibodies, and the precipitates were immunoblotted
sequentially with anti-Kv1.4 and anti-myc antibodies, as indicated. Kv1.4-EFYA, but not wild-type Kv1.4, could be coprecipitated with
CASK. Input lanes were loaded with 10% of the lysate used for the immunoprecipitation reactions.
Table I. Analysis of CASK PD2 Domain Interactions by Yeast 
Two-Hybrid System
COOH-terminus
CASK/PDZ
b-gal His
Clone 1 (Syndecan-2) KEFYA 111 1
Clone 2 (G2) FEFQV 11 1
Clone 3 TYFDV 11
Syn-2 wild-type KEFYA 111 1
Syn-2 DFYA KE222 2 2
Neurexin KEYYV 111 1
Clones 1, 2, and 3 were isolated by a yeast two-hybrid screen of brain cDNA libraries
using the CASK PDZ domain as bait. Their COOH terminal sequences (last five
amino acids) are shown in single letter code. Clone 1 is a COOH-terminal fragment of
syndecan-2 (aa 72–aa 201). Clone 2 is a COOH-terminal fragment of a gene depos-
ited in the databases as sequence G2, accession no. U10991. Clone 3 is a novel cDNA
sequence. The COOH-terminal sequece of syndecan-2 is compared with neurexin.
Deletion of the last three residues of syndecan-2 (Syn2DFYA) abolishes its binding to
the CASK PDZ domain. Yeast two-hybrid interactions are semiquantified based on
induction of reporter genes b-galactosidase and HIS3. HIS3 activity was measured by
the percentage of colonies growing on histidine-lacking medium: 111, .60%;
11, 30–60%; 1, 10–30%; 2, no significant growth. b-galactosidase activity was
measured by the time taken for colonies to turn blue in X-gal filter lift assay at room
temperature: 111, ,45 min; 11, 45–90 min; 1, 90–240 min; 2, no significant ac-
tivity. By immunoblotting, expression of the syndecan-2 DFYA construct in yeast
was similar to that of wild-type syndecan-2 (data not shown).The Journal of Cell Biology, Volume 142, 1998 146
and only occasionally within the cytoplasm of dendritic shafts
(Fig. 7, D and E). In short, these LM and EM studies indi-
cate that syndecan-2 is highly concentrated at asymmetric
(presumably excitatory) synapses of rat brain, apparently
on both pre- and postsynaptic sides of the synapse.
Colocalization of CASK and Syndecan-2 In Vivo
Based on subcellular localization of the individual pro-
teins, we reasoned that CASK and syndecan-2 distribution
might overlap in brain synapses. This prediction was con-
firmed by colocalization of these two proteins in rat brain
by double-label confocal microscopy (Fig. 9). An example
of syndecan-2 colocalization with CASK is in the mossy fi-
ber tract of the hippocampus (Fig. 9 A). Partial colocaliza-
tion (i.e., overlap) was also seen in a punctate pattern
along the dendrites of hippocampal pyramidal neurons
(Fig. 9, B and C). The partial overlap occurs because Syn-
Figure 6. Synaptic localiza-
tion of syndecan-2 in rat
brain, revealed by colocaliza-
tion of Syn-2C and synapto-
physin staining. Double-label
confocal imaging of Syn-2C
and synaptophysin staining
in (A) CA3; (B) neocortex;
(C) cerebellum; and (D) ol-
factory bulb. (E) The granule
cell layer of cerebellum is
double-labeled with synapto-
physin antibody and MSE-2,
an independent antiserum
that specifically recognizes
the extracellular domain of
syndecan-2. Each group of
images ([A1–A3], [B1–B3],
[C1–C3], [D1–D3]) repre-
sents the same field visual-
ized for Syn-2C (Cy3/red) or
for synaptophysin (FITC/
green), as indicated. (E) Syn-
decan-2 (MSE-2) was viewed
with FITC/green and synap-
tophysin with Cy3/red. Com-
posite images (A3–E3) show
colocalization of syndecan
and synaptophysin in yellow.
GC, granule cell layer; M,
molecular layer; Py, pyrami-
dal cell bodies; sl, stratum lu-
cidum. Bars: (A–D) 20 mm;
(E) 10 mm.Hsueh et al. CASK-Syndecan Interaction in Synapses 147
2C immunoreactivity is specifically localized to synaptic
puncta, whereas CASK shows additional extensive stain-
ing in somata and major dendrites. Distinctive subcellular
distributions of CASK and syndecan with overlapping lo-
calization in neuronal synapses is also shown graphically
by quantitative comparison of their immunogold distribu-
tions (Fig. 8).
We tried to demonstrate biochemical association of
CASK and syndecan-2 in brain, but failed to obtain con-
vincing coimmunoprecipitation of these two proteins from
detergent extracts of synaptosomal membranes. Several
reasons may account for this inability: first, membrane-
bound CASK is relatively insoluble and requires harsh de-
tergents for extraction that may lead to disruption of the
complex; second, our syndecan-2 antibodies were rela-
tively inefficient at immunoblotting (possibly due to the
very heterogeneous size of syndecan-2 protein resulting
from glycosaminoglycan side chains); third, CASK almost
certainly binds to multiple proteins via its PDZ domain
(e.g., other syndecan family members and neurexin), and
hence only a fraction of CASK is likely to be complexed
with syndecan-2 in the brain. In any case, the degree and
significance of the CASK–syndecan interaction in vivo still
needs to be confirmed by further biochemical and genetic
experiments.
Discussion
Subcellular Distribution of CASK
Previous biochemical studies have shown that the CASK
protein is enriched in the synaptic plasma membrane frac-
tion of brain (Hata et al., 1996). Our subcellular fraction-
ation extends this observation and reveals that CASK is
Figure 7. EM localization of syndecan-2.
(A) Type 1 (asymmetric) synapse immu-
nopositive for Syn-2C, as revealed by
preembedding immunoperoxidase stain-
ing. Electron-dense reaction product is
prominent in the presynaptic axon termi-
nal (white asterisk). It is also in the adja-
cent dendrite, both at the postsynaptic
density (arrow) and at some distance from
the synapse (arrowhead). (B) Postembed-
ding immunogold staining (18-nm parti-
cles). Arrow points to an immunopositive
asymmetric synapse; labeling can be seen
at the synaptic membrane. Labeling is also
seen at lower density over the presynaptic
axon terminal. (C) Arrow points to an im-
munopositive asymmetric axospinous syn-
apse. Dense labeling at the synaptic mem-
brane (arrow) contrasts with weaker
labeling over the axon terminal. Arrow-
head points to labeling at the base of the
dendritic spine. (D) Immunopositive
asymmetric axodendritic synapse. In this
example labeling is more conspicuous in
presynaptic axon terminal than in postsyn-
aptic dendritic shaft. (E) Labeling at
nonsynaptic dendrodendritic apposition.
Such nonsynaptic labeling, though always
sparse, was strongest at the plasma mem-
brane (arrowheads). Occasional labeling is
also seen within dendrites. (F) Field show-
ing two immunopositive axospinous syn-
apses. Gold particles concentrate around
synaptic active zones. (G) Perforated ax-
ospinous synapse showing concentration
of syndecan-2 labeling at the synaptic
membranes and in the axoplasm of the pr-
esynaptic terminal. Asterisks mark pre-
synaptic terminals. D, dendritic profile;
Sp, spine. Bars, 200 nm.The Journal of Cell Biology, Volume 142, 1998 148
also enriched in the PSD fraction where it is at least partly
resistant to detergent extraction. The synaptic localization
of CASK, revealed for the first time by immunocytochem-
istry, is consistent with its interaction with syndecan-2 (an
HSPG shown here to be concentrated in synapses) and
with neurexins (which are believed to be at least partly
synaptic in distribution; Hata et al., 1996). However,
CASK is not exclusively localized in synapses; it is also
present at nonsynaptic plasma membranes and in intracel-
lular compartments. CASK may therefore be present at a
variety of membrane domains in neurons, and its compart-
mentalization between membrane and cytoplasm may be
dynamically regulated. Components of other cell junc-
tional complexes have been shown to exist in both mem-
brane-associated and cytoplasmic compartments, one
example being b-catenin, which is both an adherens junc-
tion–associated and a cytoplasmic protein (reviewed in
Miller and Moon, 1996).
Binding Specificity of the CASK PDZ Domain
The interacting clones captured by our two-hybrid screen
suggest that the CASK PDZ domain has a binding selec-
tivity for the COOH-terminal tetrapeptide consensus se-
quence -E-F-X-V/A (Table I). Neurexins, a family of
transmembrane proteins previously shown to bind CASK
(Hata et al., 1996), terminate in -EYYV, which conforms
to this consensus. We show here that the neurexin COOH
terminus also binds to CASK via the PDZ domain (Table
I). The -E-F/Y-X-V/A consensus sequence, reached here
on the basis of yeast two-hybrid assays, is consistent with
that derived from peptide library screening using the
CASK PDZ domain (Songyang et al., 1997). Both ap-
proaches reveal that the CASK PDZ domain selects for a
valine or alanine at the COOH terminus (the 0 position)
and an aromatic side chain residue (tyrosine or phenylala-
nine) at the -2 position. Thus, the CASK PDZ domain be-
longs to the class II PDZ domains, in contrast to the class I
PDZ domains of the PSD-95 family of MAGUKs, which
prefer a serine or threonine at the -2 position (Songyang
et al., 1997). These recognition specificities are in keeping
with the fact that in C. elegans LIN-2 does not interact di-
rectly with LET-23/EGFR, which terminates with the se-
quence -ETCL.
We have shown that a tetrapeptide sequence (-EFYA,
corresponding to the COOH-terminus of syndecan-2) is
sufficient for specific interaction with the PDZ domain of
CASK. By extrapolation, any protein that ends in the
-E-F/Y-X-V/A consensus sequence may be capable of bind-
ing to CASK. Thus, the CASK PDZ domain may have
multiple binding partners in vivo, just as the PDZs of PSD-
95 can bind to several proteins with the COOH-terminal
-E-S/T-X-V motif, including Shaker K1 channels, NMDA
receptors, and calcium pumps (Kim et al., 1998; Kim et al.,
1995; Kornau et al., 1995; Niethammer et al., 1996). Con-
sistent with the idea of multiple partners for CASK is that
syndecan-2 distribution overlaps only partly with the dis-
tribution of CASK in neurons. Syndecan-2 is specifically
localized in synaptic junctions, while CASK is more
broadly distributed in synaptic and nonsynaptic sites and
in intracellular compartments. Other potential ligands for
CASK include the other members of the syndecan family,
all four of which end in the identical COOH-terminal se-
quence of -EFYA (that we only isolated syndecan-2 in our
two-hybrid screen may simply reflect the stochastic nature
of the screening procedure). It is possible that other synde-
cans (particularly syndecan-3, which is relatively highly ex-
pressed in neurons) bind to CASK in nonsynaptic regions
of the neuronal plasma membrane. In addition to the syn-
decans, of course, the neurexin intracellular COOH-termi-
nal tail has specific affinity for the CASK PDZ (this study
and Hata et al., 1996), and may be interacting with CASK
in the brain. Neurexins are proposed to be at least in part
present in synaptic membranes, based on their activity as
latrotoxin receptors (Ushkaryov et al., 1992). The struc-
ture of neurexins, however, is extremely heterogeneous
(Ullrich et al., 1995; Ushkaryov et al., 1992), and their sub-
cellular distribution remains to be characterized in detail.
Figure 8. Quantitative analy-
sis of syndecan and CASK
immunogold EM. (Left)
Graph compares axodendritic
distribution of gold particles
for syndecan-2 (filled trian-
gles) and for CASK (open
circles). Both antigens show
the highest density at the
synaptic junction (note that
measurement error of immu-
nogold labeling is z620 nm).
CASK also exhibits smaller
pre- and postsynaptic peaks.
Although peaking at the syn-
aptic membrane, syndecan-2 labeling extends deeper into the presynaptic than the postsynaptic side. 0 (dotted line) represents outer
leaflet of postsynaptic membrane. Data were collected from random fields from two animals, including 261 particles (for syndecan-2 la-
beling) and 63 particles (for CASK). To make the distribution pattern easier to see, data shown were digitally smoothed, using a three-
point moving weighted average. (Right) Histogram compares tangential position of gold particles coding for syndecan-2 (shaded bars)
and CASK (light bars). Only particles within 100 nm of the plasma membrane were considered. Tangential position for each gold particle
with respect to the synaptic active zone (AZ) was normalized according to the following formula: [(distance to one end of AZ) 2 (dis-
tance to other end of AZ)] /(total length of AZ). Thus, 0 corresponds to the AZ center, and 1 corresponds to the AZ edge. Both anti-
gens were concentrated at the AZ, though more CASK was found at the periphery of the synapse and just outside it.Hsueh et al. CASK-Syndecan Interaction in Synapses 149
Possible Functions of the Syndecan–CASK Interaction
The syndecan family, consisting of four known members,
constitutes a major form of heparan sulfate (HS) on the
cell surface (reviewed in Bernfield et al., 1992; Carey,
1997; Couchman and Woods, 1996; David, 1993). Among
the syndecans, conservation of sequence occurs only in
their short intracellular COOH-terminal tails and in their
transmembrane domains. Their striking sequence similar-
ity had implied to many observers an important common
function for intracellular COOH-terminal tails of synde-
cans. Here we show that one likely common function is to
mediate binding to CASK, though the physiological signif-
icance of this interaction is still unknown.
Expression of syndecan HSPGs is regulated during de-
velopment in a cell type–specific manner, and this regula-
tion is believed to be important for dynamic cell–matrix
interactions and for tissue morphogenesis (reviewed in
Bernfield et al., 1992; Carey, 1997; Couchman and Woods,
1996; David, 1993). Transmembrane HSPGs such as syn-
decans may be involved in cell–matrix adhesion by binding
to components of the extracellular matrix (ECM) includ-
ing laminin, fibronectin, and collagen. By virtue of their in-
teraction with CASK through their COOH-terminal tails,
syndecans could provide a molecular bridge between the
ECM and intracellular proteins. If CASK in turn interacts
with cytoskeletal components such as protein 4.1 (Cohen
et al., cosubmitted manuscript), then a syndecan–CASK
connection could link ECM to the intracellular cytoskeleton.
In such a way, a syndecan–CASK interaction may contrib-
ute to adhesion of synaptic junctions, perhaps in conjunc-
tion with the known cadherin-based adhesion complex
found at the periphery of synaptic active zones (reviewed
in Serafini, 1997).
In addition to membrane proteins, MAGUK proteins
can also interact with intracellular signaling molecules
(such as nNOS, APC). By analogy with the integrin family
of ECM receptors that nucleate an intracellular complex
of proteins at the site of ECM contact (Clark and Brugge,
1995), the syndecan–CASK interaction might form the
axis of a cytoskeletal/signaling complex at the plasma
membrane. Since all syndecans terminate with the -EFYA
sequence sufficient for binding to CASK, such a model
may apply to other members of the family in addition to
the synaptically localized syndecan-2.
Potential Signficance of CASK–Syndecan Interaction 
in Growth Factor Signaling
Recently, interest has focused on cell surface HSPGs such
as the syndecans because they bind to, and are essential
for the biological actions of, certain secreted polypeptide
factors (reviewed in Carey, 1997; Schlessinger et al., 1995).
In the best-studied example of FGF signaling, cell surface
Figure 9. Partial colocali-
zation of syndecan-2 and
CASK in rat brain, shown by
double label immunofluores-
cence confocal microscopy.
(A) Hilar region of dentate
gyrus; (B) CA4 (polymor-
phonuclear) region of hip-
pocampus; (C) CA3 region.
Each group of images ([A1–
A3], [B1–B3], etc.) repre-
sents the same field visual-
ized for CASK (Cy3/red) or
for syndecan-2 (FITC/green),
as indicated; composite im-
ages (A3, B3, and C3) show
colocalization of CASK and
syndecan-2 in yellow. P, py-
ramidal cells; sl, stratum luci-
dum. Bar, 20 mm.The Journal of Cell Biology, Volume 142, 1998 150
HSPGs are believed to be important for appropriate pre-
sentation of FGF to its high-affinity tyrosine kinase recep-
tor, or for increasing the effective concentration of FGF at
the plasma membrane. In this way, HSPGs at the plasma
membrane can be regarded as coreceptors for heparin-
binding factors, though of lower affinity and lower speci-
ficity than the specific receptor tyrosine kinases (reviewed
in Carey, 1997; Schlessinger et al., 1995).
Bearing in mind that the CASK homolog LIN-2 is re-
quired for LET23/EGFR signaling in C. elegans, the ques-
tion is raised: could the interaction between syndecan and
CASK/LIN-2 play a role in growth factor signaling? We
hypothesize that one function of CASK/LIN-2 is to bind
and cluster syndecan HSPGs in the vicinity of the growth
factor receptor. The HS side chains of syndecan can bind
to many polypeptide growth/differentiation factors; this
binding could enhance the action of the growth factor via a
concentration effect or via appropriate presentation to its
receptor tyrosine kinase. In the context of this model, it is
noteworthy that the C. elegans syndecan protein also ter-
minates in -EFYA, and is thus predicted to bind to LIN-2’s
PDZ domain. This prediction raises the possibility that
loss-of-function of LIN-2 in C. elegans could inhibit
LET23/EGF receptor signaling as a result of mislocaliza-
tion of syndecan HSPGs. In vertebrates, HSPGs have been
implicated in the action of neuregulin/ARIA, a heparin-
binding secreted factor that acts on EGFR-like receptor
tyrosine kinases (reviewed in Fischbach and Rosen, 1997).
More intriguing is that neuregulin/ARIA is concentrated
in the synaptic cleft of neuronal synapses (Sandrock et al.,
1995), where it would be in a good position to interact with
syndecan-2 HSPG. We speculate that synaptically local-
ized syndecan HSPG may be involved in binding to certain
growth factors (like neuregulins) in synapses, and in po-
tentiating their action on synaptic receptor tyrosine kinases.
Previously, HSPGs have been localized in the vertebrate
NMJ (Sanes, 1989; Sanes et al., 1986), but these HSPGs
are either not identified or are thought to be associated
with the ECM/basal lamina of the NMJ (e.g., agrin and
perlecan). In this paper we find that brain synapses also
contain a specific HSPG, thereby revealing a parallel with
the NMJ; however, this HSPG is a transmembrane protein
of the syndecan family rather than a predicted ECM pro-
tein. The localization of a cell surface HSPG in neuronal
synapses sheds some new light on the molecular organiza-
tion of synaptic junctions in the brain, and should provide
a basis for further investigation into the molecules of the
synaptic space.
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